Egyptian Liver Journal

Table 2 Plasma concentrations of miR-331-3p and miR-23b-3p in group II (n = 50)

From: The expression of microRNA-331-3p and microRNA-23b3 in Egyptian patients with early-stage hepatocellular carcinoma in hepatitis C-related liver cirrhosis

	BCLC stage		U	p
	Stage 0 (n = 16)	Stage A (n = 34)	U	p
miR-331-3p (2^−∆CT)
Mean ± SD	8.1 ± 10.3	7.3 ± 10.1	270.0	0.967
Median (min.–max.)	3.8 (1.3–36.2)	3.7 (0.1–41)	270.0	0.967
miR-23b-3p (2^−∆CT)
Mean ± SD	0.21 ± 0.22	0.31 ± 0.37	229.0	0.371
Median (min.–max.)	0.14 (0.01–0.8)	0.18 (0.02–1.7)	229.0	0.371

U Mann-Whitney test, p p value for comparing between BCLC stage and serum concentrations of miR-331-3p and miR-23b-3p

Back to article page